Your browser doesn't support javascript.
loading
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.
Boidol, Bernd; Kornauth, Christoph; van der Kouwe, Emiel; Prutsch, Nicole; Kazianka, Lukas; Gültekin, Sinan; Hoermann, Gregor; Mayerhoefer, Marius E; Hopfinger, Georg; Hauswirth, Alexander; Panny, Michael; Aretin, Marie-Bernadette; Hilgarth, Bernadette; Sperr, Wolfgang R; Valent, Peter; Simonitsch-Klupp, Ingrid; Moriggl, Richard; Merkel, Olaf; Kenner, Lukas; Jäger, Ulrich; Kubicek, Stefan; Staber, Philipp B.
Afiliación
  • Boidol B; Research Center for Molecular Medicine (CeMM) and.
  • Kornauth C; Christian Doppler Laboratory for Chemical Epigenetics and Anti-Infectives, Austrian Academy of Sciences, Vienna, Austria.
  • van der Kouwe E; Division of Hematology and Hemostaseology, Department of Internal Medicine I.
  • Prutsch N; Clinical Institute of Pathology.
  • Kazianka L; Division of Hematology and Hemostaseology, Department of Internal Medicine I.
  • Gültekin S; Clinical Institute of Pathology.
  • Hoermann G; Division of Hematology and Hemostaseology, Department of Internal Medicine I.
  • Mayerhoefer ME; Division of Hematology and Hemostaseology, Department of Internal Medicine I.
  • Hopfinger G; Department of Laboratory Medicine, and.
  • Hauswirth A; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Panny M; Division of Hematology and Hemostaseology, Department of Internal Medicine I.
  • Aretin MB; Division of Hematology and Hemostaseology, Department of Internal Medicine I.
  • Hilgarth B; 3rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria.
  • Sperr WR; Pharmacy Department, General Hospital and.
  • Valent P; Division of Hematology and Hemostaseology, Department of Internal Medicine I.
  • Simonitsch-Klupp I; Division of Hematology and Hemostaseology, Department of Internal Medicine I.
  • Moriggl R; Division of Hematology and Hemostaseology, Department of Internal Medicine I.
  • Merkel O; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Kenner L; Clinical Institute of Pathology.
  • Jäger U; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.
  • Kubicek S; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria; and.
  • Staber PB; Medical University of Vienna, Vienna, Austria.
Blood ; 130(23): 2499-2503, 2017 12 07.
Article en En | MEDLINE | ID: mdl-28972014
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Prolinfocítica de Células T / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteínas Proto-Oncogénicas c-bcl-2 / Terapia Molecular Dirigida / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Prolinfocítica de Células T / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteínas Proto-Oncogénicas c-bcl-2 / Terapia Molecular Dirigida / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article